— Know what they know.
Not Investment Advice

BRSF OTC

Brain Scientific Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +500.0% 1Y: -99.9% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 50 · $746 mcap · 878010 float · 0.0002% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$12M -12.2% ▼
5Y CAGR: +106.9%
Total Liabilities
$7M -47.2% ▼
5Y CAGR: +43.5%
Shareholders Equity
$4M +721.2% ▲
Cash & Investments
$748K -4.8% ▼
5Y CAGR: +20.2%
Total Debt
$3M -73.1% ▼
5Y CAGR: +21.3%
Net Debt
$2M -78.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$164K$261K$69K$785K$748K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$164K$261K$69K$785K$748K
Net Receivables$0$6K$1K$17K$947
Inventory$0$0$45K$146K$150K
Other Current Assets$0$0$11K$31K$89K
Total Current Assets$178K$289K$133K$1M$1M
Property, Plant & Equip.$2K$2K$92K$315K$209K
Goodwill & Intangibles$0$0$0$12M$10M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$95K$75K
Total Non-Current Assets$2K$2K$92K$12M$10M
Total Assets$180K$291K$225K$13M$12M
— Liabilities —
Accounts Payable$140K$308K$398K$1M$1M
Short-Term Debt$50K$872K$650K$820K$3M
Deferred Revenue$0-$879K$0$36K$9K
Other Current Liabilities$0$879K$76K$0$2M
Total Current Liabilities$227K$1M$2M$4M$7M
Long-Term Debt$0$0$111K$10M$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$7K$0$111K$10M$7K
Total Liabilities$234K$1M$2M$14M$7M
— Equity —
Common Stock$19K$19K$30K$594$1K
Retained Earnings-$3M-$4M-$13M-$22M-$35M
Accumulated OCI$0$366-$4.1B-$4K-$4K
Total Stockholders Equity-$54K-$896K-$2M-$695K$4M
Total Liabilities & Equity$180K$291K$225K$13M$12M
— Key Metrics —
Total Debt$63K$879K$761K$11M$3M
Net Debt-$101K$617K$693K$10M$2M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms